-
AOD9604 is a synthetic peptide fragment derived from human growth hormone (hGH), specifically from the 176-191 amino acid region of the hGH molecule. It was developed to mimic the fat-reducing (lipolytic) effects of hGH without the growth-promoting effects typically associated with the full hormone. -
BPC-157 and TB-500 (Thymosin Beta-4) are peptides often explored for their potential roles in enhancing tissue repair and regeneration. Each peptide works through unique, yet complementary biological mechanisms, and their combined use may produce synergistic effects. -
Tesamorelin is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH), composed of 44 amino acids with a structural modification that enhances its stability and half-life. Although it has gained regulatory approval as Egrifta® for the treatment of HIV-associated lipodystrophy, tesamorelin is also widely investigated in the broader research context. -
The KLOW peptide complex builds upon the foundational GLOW formulation by integrating KPV into the existing triad of BPC-157, TB500 (Thymosin Beta-4), and GHK-Cu, creating a four-component system being evaluated for its synergistic effects on regenerative biology. -
Triple receptor agonist: Retatrutide (also known as LY-3437943) simultaneously targets three receptors GLP-1, GIP, and glucagon (GCG). This sets it apart from single (e.g., semaglutide) or dual agonists (e.g., tirzepatide) -
Triple receptor agonist: Retatrutide (also known as LY-3437943) simultaneously targets three receptors GLP-1, GIP, and glucagon (GCG). This sets it apart from single (e.g., semaglutide) or dual agonists (e.g., tirzepatide) -
Triple receptor agonist: Retatrutide (also known as LY-3437943) simultaneously targets three receptors GLP-1, GIP, and glucagon (GCG). This sets it apart from single (e.g., semaglutide) or dual agonists (e.g., tirzepatide) -
Triple receptor agonist: Retatrutide (also known as LY-3437943) simultaneously targets three receptors GLP-1, GIP, and glucagon (GCG). This sets it apart from single (e.g., semaglutide) or dual agonists (e.g., tirzepatide) -
BPC-157 is a peptide made up of 15 amino acids, originally discovered in human gastric juice. Research shows that it supports faster healing of muscles, tendons, ligaments, and even skin injuries such as burns. It also helps protect organs and may prevent gastric ulcers. In the digestive system, BPC-157 has been shown to support gut health by helping with issues like leaky gut, IBS, cramps, and Crohn’s disease. In addition, it may reduce pain and speed up recovery by improving blood flow, boosting collagen production, and supporting new tissue and blood vessel growth. Because of these benefits, BPC-157 is being studied as a promising option for wound healing and overall recovery support. -
BPC-157 is a peptide made up of 15 amino acids, originally discovered in human gastric juice. Research shows that it supports faster healing of muscles, tendons, ligaments, and even skin injuries such as burns. It also helps protect organs and may prevent gastric ulcers. In the digestive system, BPC-157 has been shown to support gut health by helping with issues like leaky gut, IBS, cramps, and Crohn’s disease. In addition, it may reduce pain and speed up recovery by improving blood flow, boosting collagen production, and supporting new tissue and blood vessel growth. Because of these benefits, BPC-157 is being studied as a promising option for wound healing and overall recovery support. -
BPC-157 is a peptide made up of 15 amino acids, originally discovered in human gastric juice. Research shows that it supports faster healing of muscles, tendons, ligaments, and even skin injuries such as burns. It also helps protect organs and may prevent gastric ulcers. In the digestive system, BPC-157 has been shown to support gut health by helping with issues like leaky gut, IBS, cramps, and Crohn’s disease. In addition, it may reduce pain and speed up recovery by improving blood flow, boosting collagen production, and supporting new tissue and blood vessel growth. Because of these benefits, BPC-157 is being studied as a promising option for wound healing and overall recovery support. -
BPC-157 is a peptide made up of 15 amino acids, originally discovered in human gastric juice. Research shows that it supports faster healing of muscles, tendons, ligaments, and even skin injuries such as burns. It also helps protect organs and may prevent gastric ulcers. In the digestive system, BPC-157 has been shown to support gut health by helping with issues like leaky gut, IBS, cramps, and Crohn’s disease. In addition, it may reduce pain and speed up recovery by improving blood flow, boosting collagen production, and supporting new tissue and blood vessel growth. Because of these benefits, BPC-157 is being studied as a promising option for wound healing and overall recovery support.
Need help? Call Or Text us, and a team member will be happy to assist you. +1 (570) 539-9711
Need help? Call Or Text us, and a team member will be happy to assist you.
+1 (570) 539-9711
We take pride in providing every client, whether large or small, with dedicated and respectful service.
We take pride in providing every client, whether large or small, with dedicated and respectful service.
© 2025
Licensedpeptides.com. All Rights Reserved.
LicensedPeptides is a licensed business entity supplying compounds for laboratory research purposes only. No products are approved for human use.
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Licensed peptides is a chemical supplier. Licensed peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Licensed peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.